Vicor FY2026 revenue expected to exceed $600 million
Vicor Corporation raised its FY2026 revenue outlook to exceed $600 million, surpassing analyst estimates of $593.340 million. Q2 revenue increased 26.9% sequentially to $143.4 million, supported by a 45% rise in advanced products revenue and a new licensing agreement. The company reported a gross margin of 58% and net income of $49.8 million, with long-term targets of $2.5 billion in revenue.

*this image is generated using AI for illustrative purposes only.
Vicor Corporation projects FY2026 revenue to exceed $600 million, surpassing the estimated $593.340 million. This outlook follows a strong Q2 2026 performance, where revenue rose 26.9% sequentially to $143.4 million, driven by a 45% increase in advanced products revenue. The company reported a consolidated gross profit margin of 58%, an increase of 280 basis points from the prior quarter, and net income of $49.8 million.
Financial Performance
The company's total operating expenses increased 6.1% sequentially to $48.2 million, attributed partly to contingent legal expenses associated with a new license agreement. Vicor recorded a tax benefit of approximately $10.9 million for the quarter, resulting in an effective tax rate of -27.9%. Accounts receivable totaled $78.9 million at quarter end, with days sales outstanding at 37 days. Inventories increased 10.2% sequentially to $104.5 million.
Key Metrics
| Metric | Q2 2026 Value | Sequential Change |
|---|---|---|
| Revenue | $143.4 million | +26.9% |
| Advanced Products Revenue | $94.2 million | +45.0% |
| Gross Profit Margin | 58% | +280 bps |
| Net Income | $49.8 million | N/A |
| GAAP Diluted EPS | $1.04 | N/A |
| Cash and Equivalents | $453.6 million | +$49.4 million |
Operational Highlights
A new licensing agreement contributed $15 million to Q2 revenue. The agreement provides for four $5 million quarterly payments in the first year and $10 million quarterly payments in the second year. Vicor expects this agreement to contribute $5 million in Q3 and $10 million per quarter for the following four quarters. Book-to-bill for the quarter was above one, with a one-year backlog increasing 26% sequentially to $379.7 million.
Outlook
Management expects Q3 revenue to increase nearly 10% year over year. The company anticipates over $600 million in revenue for 2026 and is planning for double-digit sequential increases in product revenue for advanced products. Vicor is also pursuing a second chip fab to support long-term growth, with financial objectives targeting $2.5 billion in revenue at 70% gross margins.
What is the timeline for securing the second chip fab, and how will capital expenditures impact cash flow in the near term?
Can the 45% growth in advanced products revenue be sustained as the licensing agreement contributions shift to lower levels?
What specific end markets are driving the backlog growth, and are there signs of demand softening on the horizon?




























